Exchange Traded Concepts LLC raised its position in Dolby Laboratories (NYSE:DLB – Free Report) by 8.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,776 shares of the electronics maker’s stock after acquiring an additional 1,008 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Dolby Laboratories were worth $949,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DLB. Bank of New York Mellon Corp raised its holdings in Dolby Laboratories by 18.3% during the first quarter. Bank of New York Mellon Corp now owns 5,709,193 shares of the electronics maker’s stock worth $458,505,000 after purchasing an additional 882,716 shares in the last quarter. Vanguard Group Inc. grew its position in Dolby Laboratories by 7.1% in the 1st quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker’s stock valued at $605,194,000 after buying an additional 502,110 shares during the last quarter. AQR Capital Management LLC grew its position in Dolby Laboratories by 63.6% in the 1st quarter. AQR Capital Management LLC now owns 1,143,978 shares of the electronics maker’s stock valued at $90,946,000 after buying an additional 444,718 shares during the last quarter. Jones Financial Companies Lllp grew its position in Dolby Laboratories by 241,160.1% in the 1st quarter. Jones Financial Companies Lllp now owns 429,443 shares of the electronics maker’s stock valued at $36,975,000 after buying an additional 429,265 shares during the last quarter. Finally, Nuveen LLC acquired a new position in shares of Dolby Laboratories during the 1st quarter worth $16,890,000. Institutional investors and hedge funds own 58.56% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts recently commented on the stock. Tigress Financial boosted their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a research report on Friday, August 15th. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, August 30th. Robert W. Baird assumed coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They set a “neutral” rating and a $74.00 price objective for the company. Finally, Rosenblatt Securities reaffirmed a “buy” rating and set a $95.00 price objective on shares of Dolby Laboratories in a research note on Friday, August 1st. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $95.75.
Insider Buying and Selling at Dolby Laboratories
In other news, SVP Shriram Revankar sold 7,000 shares of the firm’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the transaction, the senior vice president directly owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. This trade represents a 9.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin J. Yeaman sold 25,000 shares of Dolby Laboratories stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $71.66, for a total value of $1,791,500.00. Following the transaction, the chief executive officer directly owned 114,725 shares in the company, valued at approximately $8,221,193.50. The trade was a 17.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 99,366 shares of company stock worth $7,293,963 over the last ninety days. 38.39% of the stock is owned by corporate insiders.
Dolby Laboratories Trading Down 0.3%
Dolby Laboratories stock opened at $72.16 on Wednesday. The stock has a market cap of $6.92 billion, a P/E ratio of 26.43 and a beta of 0.93. The stock has a 50 day moving average of $73.28 and a 200-day moving average of $75.01. Dolby Laboratories has a 52 week low of $68.24 and a 52 week high of $89.66.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its earnings results on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, beating the consensus estimate of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The company had revenue of $315.55 million during the quarter, compared to analysts’ expectations of $305.23 million. During the same period in the prior year, the business posted $0.71 EPS. The business’s revenue was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, equities analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.
Dolby Laboratories Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were given a $0.33 dividend. The ex-dividend date of this dividend was Tuesday, August 12th. This represents a $1.32 annualized dividend and a yield of 1.8%. Dolby Laboratories’s dividend payout ratio (DPR) is currently 48.35%.
Dolby Laboratories Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- What is Short Interest? How to Use It
- 3 Quantum Computing ETFs to Know—And Why 2 Don’t Hold D-Wave
- How to trade using analyst ratings
- Forget Tariffs, Landstar and West Fraser Can Still Rally
- P/E Ratio Calculation: How to Assess Stocks
- Is Super Micro Next in Line for a Big AI Takeover?
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.